Gannet Pharma Solutions Llp - Company Profile

It is a business services limited liability partnership based in Nagpur, Maharashtra, India, established in 2016.
2016 Nagpur, Maharashtra, India Struck Off
Last Updated:
Access Report
About Gannet Pharma Solutions Llp

Gannet Pharma Solutions Llp, a struck off limited liability partnership, was established on 27 May 2016 in Nagpur, Maharashtra, India. Engaging in other services within the business services sector, it holds LLPIN: AAG-4896. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹75.00 K .

Its leadership includes Hema Shrinivas Savale (Designated Partner), Nidhi Prakash Sapkal (Designated Partner), Sumati Laxman Gokhale (Designated Partner). Its latest date of accounts and solvency statement 31 March 2023. It is based at H No 1288/D/204 Nandanwan, Nagpur, Maharashtra, 440009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAG-4896

  • Incorporation Date

    27 May 2016

  • Total Obligation of Contribution

    ₹75.00 K

  • ROC Code

    Roc Mumbai

  • Company Status

    Struck Off

Key Metrics
  • Obligation of Contribution ₹ 75.00 K
  • Company Age 9 Year, 9 Months
  • Last Filing with ROC 31 Mar 2023
Company report

Gannet Pharma Solutions Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gannet Pharma Solutions Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gannet Pharma Solutions Llp?
Current Designated Partners
Name Designation Appointment Date Status
Hema Shrinivas Savale Designated Partner 27 May 2016 Current
Nidhi Prakash Sapkal Designated Partner 28 Jun 2016 Current
Sumati Laxman Gokhale Designated Partner 27 May 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gannet Pharma Solutions Llp.

Enhance accessibility to Gannet Pharma Solutions Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gannet Pharma Solutions Llp revenue growth over time
Gannet Pharma Solutions Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gannet Pharma Solutions Llp?

Unlock access to Gannet Pharma Solutions Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gannet Pharma Solutions Llp?

Unlock and access historical data on people associated with Gannet Pharma Solutions Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gannet Pharma Solutions Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gannet Pharma Solutions Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gannet Pharma Solutions Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Gannet Pharma Solutions Llp last Annual general meeting of members was held on 31 Mar 2023 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Gannet Pharma Solutions Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Progress on Nidhi Prakash Sapkal was appointed as a Designated Partner was appointed as a Designated Partner on 28 Jun 2016 & has been associated with this company since 9 years 8 months . was documented.

  • Director Appointment

    Hema Shrinivas Savale was appointed as a Designated Partner was appointed as a Designated Partner on 27 May 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sumati Laxman Gokhale was appointed as a Designated Partner was appointed as a Designated Partner on 27 May 2016 & has been associated with this company since 9 years 9 months . was documented.

  • LLP Incorporation

    The activity Gannet Pharma Solutions Llp was registered on 27 May 2016 with Roc Mumbai & aged 9 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Gannet Pharma Solutions Llp?

The LLPIN of Gannet Pharma Solutions Llp is AAG-4896.

Where is Gannet Pharma Solutions Llp headquartered?

Gannet Pharma Solutions Llp is headquartered at H No 1288/D/204 Nandanwan, Nagpur, Maharashtra, 440009.

When was Gannet Pharma Solutions Llp incorporated?

Gannet Pharma Solutions Llp was incorporated on 27 May 2016.

Who are the current directors of Gannet Pharma Solutions Llp?

The current directors of Gannet Pharma Solutions Llp are

What is the primary industry of Gannet Pharma Solutions Llp?

The primary industry of Gannet Pharma Solutions Llp is Business Services.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available